Health Recover Solutions Acquires Rimidi

HOBOKEN, New Jersey—Health Recovery Solutions (HRS), a national remote patient monitoring and enterprise remote patient care platform, announced its acquisition of Rimidi, a chronic disease management and remote monitoring company with deep roots in diabetes and cardiometabolic management.

The companies said this acquisition enables HRS customers to access Rimidi’s capabilities, including advanced diabetes management with continuous glucose monitoring integration, through a single partner, simplifying procurement, training and support.

“HRS is committed to expanding enterprise remote patient care to meet evolving customer needs,” said Jason Comer, CEO of HRS. “With our recent introduction of PatientFirst Pathways and expansion into chronic care management, this acquisition enhances our ability to deliver comprehensive longitudinal care. Rimidi’s clinical workflow expertise, deep roots in diabetes management and strong track record of improving patient outcomes make them an ideal addition.”

HRS said its current customers will benefit from diabetes and clinical management capabilities alongside their existing PatientConnect platform, while Rimidi customers will gain access to HRS’s comprehensive enterprise remote patient care ecosystem. The companies said integration will continue throughout the year, and both companies agree the process is designed to be seamless, with dedicated support teams in place to ensure minimal disruption to ongoing patient care programs.

“HRS’s leadership in enterprise remote patient care and dedication to quality perfectly complement the mission Rimidi was founded on,” said Lucienne Ide, CEO and founder of Rimidi, and now chief medical officer for HRS. “By integrating Rimidi’s extensive experience and capabilities in ambulatory disease management into their comprehensive platform, we can jointly support the entire patient journey across care settings, clinical conditions and levels of patient acuity. Our combined solutions will enhance the reach and effectiveness of HRS’s already high‑value offerings, amplifying the positive impact we can make on patient outcomes.”